IBDEI0XH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14910,0)
 ;;=K31.89^^85^836^78
 ;;^UTILITY(U,$J,358.3,14910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14910,1,3,0)
 ;;=3^Portal hypertension gastropathy
 ;;^UTILITY(U,$J,358.3,14910,1,4,0)
 ;;=4^K31.89
 ;;^UTILITY(U,$J,358.3,14910,2)
 ;;=^5008569
 ;;^UTILITY(U,$J,358.3,14911,0)
 ;;=I81.^^85^836^79
 ;;^UTILITY(U,$J,358.3,14911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14911,1,3,0)
 ;;=3^Portal vein thrombosis
 ;;^UTILITY(U,$J,358.3,14911,1,4,0)
 ;;=4^I81.
 ;;^UTILITY(U,$J,358.3,14911,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,14912,0)
 ;;=K74.4^^85^836^81
 ;;^UTILITY(U,$J,358.3,14912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14912,1,3,0)
 ;;=3^Secondary biliary cirrhosis
 ;;^UTILITY(U,$J,358.3,14912,1,4,0)
 ;;=4^K74.4
 ;;^UTILITY(U,$J,358.3,14912,2)
 ;;=^5008820
 ;;^UTILITY(U,$J,358.3,14913,0)
 ;;=K65.2^^85^836^83
 ;;^UTILITY(U,$J,358.3,14913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14913,1,3,0)
 ;;=3^Spontaneous bacterial peritonitis
 ;;^UTILITY(U,$J,358.3,14913,1,4,0)
 ;;=4^K65.2
 ;;^UTILITY(U,$J,358.3,14913,2)
 ;;=^332801
 ;;^UTILITY(U,$J,358.3,14914,0)
 ;;=K71.2^^85^836^85
 ;;^UTILITY(U,$J,358.3,14914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14914,1,3,0)
 ;;=3^Toxic liver disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,14914,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,14914,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,14915,0)
 ;;=K71.3^^85^836^87
 ;;^UTILITY(U,$J,358.3,14915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14915,1,3,0)
 ;;=3^Toxic liver disease w/ Chronic Hepatitis
 ;;^UTILITY(U,$J,358.3,14915,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,14915,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,14916,0)
 ;;=K71.0^^85^836^86
 ;;^UTILITY(U,$J,358.3,14916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14916,1,3,0)
 ;;=3^Toxic liver disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,14916,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,14916,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,14917,0)
 ;;=K71.10^^85^836^89
 ;;^UTILITY(U,$J,358.3,14917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14917,1,3,0)
 ;;=3^Toxic liver disease w/ Hepatic Necrosis
 ;;^UTILITY(U,$J,358.3,14917,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,14917,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,14918,0)
 ;;=K71.6^^85^836^90
 ;;^UTILITY(U,$J,358.3,14918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14918,1,3,0)
 ;;=3^Toxic liver disease w/ Hepatitis
 ;;^UTILITY(U,$J,358.3,14918,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,14918,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,14919,0)
 ;;=K71.11^^85^836^88
 ;;^UTILITY(U,$J,358.3,14919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14919,1,3,0)
 ;;=3^Toxic liver disease w/ Coma
 ;;^UTILITY(U,$J,358.3,14919,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,14919,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,14920,0)
 ;;=K71.9^^85^836^91
 ;;^UTILITY(U,$J,358.3,14920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14920,1,3,0)
 ;;=3^Toxic liver disease,Uncomplicated
 ;;^UTILITY(U,$J,358.3,14920,1,4,0)
 ;;=4^K71.9
 ;;^UTILITY(U,$J,358.3,14920,2)
 ;;=^5008804
 ;;^UTILITY(U,$J,358.3,14921,0)
 ;;=E83.01^^85^836^92
 ;;^UTILITY(U,$J,358.3,14921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14921,1,3,0)
 ;;=3^Wilson's disease
 ;;^UTILITY(U,$J,358.3,14921,1,4,0)
 ;;=4^E83.01
 ;;^UTILITY(U,$J,358.3,14921,2)
 ;;=^5002991
 ;;^UTILITY(U,$J,358.3,14922,0)
 ;;=K76.9^^85^836^24
 ;;^UTILITY(U,$J,358.3,14922,1,0)
 ;;=^358.31IA^4^2
